Publications de la R&D d'Unicancer


GEMO, a national resource to study genetic modifiers of breast and ovarian cancer risk in BRCA1 and BRCA2 pathogenic variant carriers

Lesueur F. et al, Front Oncol. 2018 Oct 31;8:490. doi: 10.3389/fonc.2018.00490. eCollection 2018.


The Influence of Number and Timing of Pregnancies on Breast Cancer Risk in Women with BRCA1 and BRCA2 mutations

Terry MB et al, JNCI Cancer Spectr. 2018 Dec;2(4):pky078. doi: 10.1093/jncics/pky078. Epub 2019 Mar 8.


Efficacy of Anthracycline/taxane based neoadjuvant chemotherapy on Triple-Negative Breast Cancer in BRCA1 / BRCA2 mutation carriers.

Bignon L. et al, Breast J 2018 Volume24, Issue3May/June 2018Pages 269-277. Article DOI: 10.1111/tbj.12887


Mutation screening of MIR146A/B and BRCA1/2 3'UTRs in the GENESIS study

Garcia AI et al., Eur J Hum Genet. 2016 Aug;24(9):1324-9.


"Maybe they have found something new" participants' views on returning cohort psychosocial survey results.

Bureau E et al, Health Expect. 2015 Dec;18(6):2425-36. doi: 10.1111/hex.12211. Epub 2014 May 30